Shares of Aurobindo Pharma today rose nearly 3 per cent to touch its all-time high of Rs 1,100 on the Bombay Stock Exchange, amid reports that the company may strike a supply deal with a multinational company.
The scrip zoomed by nearly 3 per cent to touch a lifetime high at Rs 1,100 on the Bombay Stock Exchange. Later, the scrip was quoting at Rs 1,090.05, up nearly 2 per cent.
On the National Stock Exchange, the scrip moved up nearly 2 per cent to 1,093.45 a share.
According to reports, Aurobindo Pharma is likely to sign a supply deal with AstraZeneca. The Indian pharma company may get $50 million from upfront or leasing components.
Meanwhile, the entire pharma pack was riding high up as much as 10 per cent, led by Wockhardt which hit its upper circuit limit at Rs 246.30.
Ranbaxy Laboratories too hit its month high at Rs 492.05 in early trade. Later it was trading up 3 per cent at Rs 490.20 a share.
Other pharma firms which were trading higher, include Lupin (up 2.33 per cent), Cipla (up 1.76 per cent), Cadila Healthcare (nearly 1 per cent).
